SidaSubSaharaV1, Ncbi, Checkpoint, bibRecord, 002417

Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection.

Identifieur interne : 002417 ( Ncbi/Checkpoint ); précédent : 002416; suivant : 002418

Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection.

Auteurs : Tanuja N. Gengiah [Afrique du Sud] ; Atika Moosa ; Anushka Naidoo ; Leila E. Mansoor

Source :

International journal of clinical pharmacy [ 2210-7711 ] ; 2014.

RBID : pubmed:24129582

Descripteurs français

KwdFr :
- Administration par voie orale, Administration par voie topique, Agents antiVIH (administration et posologie), Agents antiVIH (pharmacologie), Agents antiVIH (usage thérapeutique), Humains, Infections à VIH (), Infections à VIH (psychologie), Infections à VIH (traitement médicamenteux), Observance du traitement médicamenteux (psychologie).
MESH :
- administration et posologie : Agents antiVIH.
- pharmacologie : Agents antiVIH.
- psychologie : Infections à VIH, Observance du traitement médicamenteux.
- traitement médicamenteux : Infections à VIH.
- usage thérapeutique : Agents antiVIH.
- Administration par voie orale, Administration par voie topique, Humains, Infections à VIH.

English descriptors

KwdEn :
- Administration, Oral, Administration, Topical, Anti-HIV Agents (administration & dosage), Anti-HIV Agents (pharmacology), Anti-HIV Agents (therapeutic use), HIV Infections (drug therapy), HIV Infections (prevention & control), HIV Infections (psychology), Humans, Medication Adherence (psychology).
MESH :
- chemical , administration & dosage : Anti-HIV Agents.
- chemical , pharmacology : Anti-HIV Agents.
- chemical , therapeutic use : Anti-HIV Agents.
- drug therapy : HIV Infections.
- prevention & control : HIV Infections.
- psychology : HIV Infections, Medication Adherence.
- Administration, Oral, Administration, Topical, Humans.

Abstract

There are 34 million people living with human immunodeficiency virus (HIV) worldwide and each year this number increases. Until a vaccine is discovered, the prevention of new HIV infections remains an urgent priority. Several trials studying the use of oral and topical agents for the prevention of HIV infection have already been completed. Adherence has proved to be a major challenge in achieving product efficacy.

DOI: 10.1007/s11096-013-9861-1
PubMed: 24129582

Affiliations:

Afrique du Sud

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001647
to stream PubMed, to step Curation: 001647
to stream PubMed, to step Checkpoint: 001647
to stream Ncbi, to step Merge: 002417
to stream Ncbi, to step Curation: 002417

Links to Exploration step

pubmed:24129582

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection.</title>
<author><name sortKey="Gengiah, Tanuja N" sort="Gengiah, Tanuja N" uniqKey="Gengiah T" first="Tanuja N" last="Gengiah">Tanuja N. Gengiah</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for the AIDS Programme of Research in South Africa (CAPRISA), 2nd Floor, K-RITH Tower Building, University of KwaZulu-Natal, 719 Umbilo Road, Durban, 4001, South Africa, gengiaht1@ukzn.ac.za.</nlm:affiliation>
<country wicri:rule="url">Afrique du Sud</country>
<wicri:regionArea>Centre for the AIDS Programme of Research in South Africa (CAPRISA), 2nd Floor, K-RITH Tower Building, University of KwaZulu-Natal, 719 Umbilo Road, Durban, 4001, South Africa</wicri:regionArea>
<wicri:noRegion>South Africa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Moosa, Atika" sort="Moosa, Atika" uniqKey="Moosa A" first="Atika" last="Moosa">Atika Moosa</name>
</author>
<author><name sortKey="Naidoo, Anushka" sort="Naidoo, Anushka" uniqKey="Naidoo A" first="Anushka" last="Naidoo">Anushka Naidoo</name>
</author>
<author><name sortKey="Mansoor, Leila E" sort="Mansoor, Leila E" uniqKey="Mansoor L" first="Leila E" last="Mansoor">Leila E. Mansoor</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24129582</idno>
<idno type="pmid">24129582</idno>
<idno type="doi">10.1007/s11096-013-9861-1</idno>
<idno type="wicri:Area/PubMed/Corpus">001647</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001647</idno>
<idno type="wicri:Area/PubMed/Curation">001647</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001647</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001647</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001647</idno>
<idno type="wicri:Area/Ncbi/Merge">002417</idno>
<idno type="wicri:Area/Ncbi/Curation">002417</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002417</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection.</title>
<author><name sortKey="Gengiah, Tanuja N" sort="Gengiah, Tanuja N" uniqKey="Gengiah T" first="Tanuja N" last="Gengiah">Tanuja N. Gengiah</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for the AIDS Programme of Research in South Africa (CAPRISA), 2nd Floor, K-RITH Tower Building, University of KwaZulu-Natal, 719 Umbilo Road, Durban, 4001, South Africa, gengiaht1@ukzn.ac.za.</nlm:affiliation>
<country wicri:rule="url">Afrique du Sud</country>
<wicri:regionArea>Centre for the AIDS Programme of Research in South Africa (CAPRISA), 2nd Floor, K-RITH Tower Building, University of KwaZulu-Natal, 719 Umbilo Road, Durban, 4001, South Africa</wicri:regionArea>
<wicri:noRegion>South Africa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Moosa, Atika" sort="Moosa, Atika" uniqKey="Moosa A" first="Atika" last="Moosa">Atika Moosa</name>
</author>
<author><name sortKey="Naidoo, Anushka" sort="Naidoo, Anushka" uniqKey="Naidoo A" first="Anushka" last="Naidoo">Anushka Naidoo</name>
</author>
<author><name sortKey="Mansoor, Leila E" sort="Mansoor, Leila E" uniqKey="Mansoor L" first="Leila E" last="Mansoor">Leila E. Mansoor</name>
</author>
</analytic>
<series><title level="j">International journal of clinical pharmacy</title>
<idno type="eISSN">2210-7711</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term>
<term>Administration, Topical</term>
<term>Anti-HIV Agents (administration & dosage)</term>
<term>Anti-HIV Agents (pharmacology)</term>
<term>Anti-HIV Agents (therapeutic use)</term>
<term>HIV Infections (drug therapy)</term>
<term>HIV Infections (prevention & control)</term>
<term>HIV Infections (psychology)</term>
<term>Humans</term>
<term>Medication Adherence (psychology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie orale</term>
<term>Administration par voie topique</term>
<term>Agents antiVIH (administration et posologie)</term>
<term>Agents antiVIH (pharmacologie)</term>
<term>Agents antiVIH (usage thérapeutique)</term>
<term>Humains</term>
<term>Infections à VIH ()</term>
<term>Infections à VIH (psychologie)</term>
<term>Infections à VIH (traitement médicamenteux)</term>
<term>Observance du traitement médicamenteux (psychologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-HIV Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-HIV Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Agents antiVIH</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Agents antiVIH</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Infections à VIH</term>
<term>Observance du traitement médicamenteux</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>HIV Infections</term>
<term>Medication Adherence</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents antiVIH</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term>
<term>Administration, Topical</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Administration par voie orale</term>
<term>Administration par voie topique</term>
<term>Humains</term>
<term>Infections à VIH</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">There are 34 million people living with human immunodeficiency virus (HIV) worldwide and each year this number increases. Until a vaccine is discovered, the prevention of new HIV infections remains an urgent priority. Several trials studying the use of oral and topical agents for the prevention of HIV infection have already been completed. Adherence has proved to be a major challenge in achieving product efficacy.</div>
</front>
</TEI>
<affiliations><list><country><li>Afrique du Sud</li>
</country>
</list>
<tree><noCountry><name sortKey="Mansoor, Leila E" sort="Mansoor, Leila E" uniqKey="Mansoor L" first="Leila E" last="Mansoor">Leila E. Mansoor</name>
<name sortKey="Moosa, Atika" sort="Moosa, Atika" uniqKey="Moosa A" first="Atika" last="Moosa">Atika Moosa</name>
<name sortKey="Naidoo, Anushka" sort="Naidoo, Anushka" uniqKey="Naidoo A" first="Anushka" last="Naidoo">Anushka Naidoo</name>
</noCountry>
<country name="Afrique du Sud"><noRegion><name sortKey="Gengiah, Tanuja N" sort="Gengiah, Tanuja N" uniqKey="Gengiah T" first="Tanuja N" last="Gengiah">Tanuja N. Gengiah</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002417 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 002417 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:24129582
   |texte=   Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i   -Sk "pubmed:24129582" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaSubSaharaV1

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024

	Le SIDA en Afrique subsaharienne (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA en Afrique subsaharienne (serveur d'exploration)

Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection.

Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki